Laser Med Center receives FDA approval for device to treat Trigeminal Neuralgia

Published on September 19, 2011 at 11:36 AM · 1 Comment

Laser Med Center, which specializes in treating Trigeminal Neuralgia, has received an FDA approval for its revolutionary laser device. This is a non-invasive alternative to surgery, which treats pain through nerve tissue regeneration.

Trigeminal Neuralgia is a terribly painful condition of the trigeminal nerve in the face. The trigeminal nerve (the fifth cranial nerve or CN5) is primarily a sensory nerve and is responsible for facial sensation.  Laser Med Center has had a great deal of success treating the pain associated with Classic and Atypical Trigeminal Neuralgia as well as Post-herpetic Neuralgia and Atypical Facial Pain.

Mr. Sawyer a 60 year-old gentleman that has had life-altering struggles with Trigeminal Neuralgia since 2005, has finally gotten his life back and has provided Laser Med Center with his success story below, for the world to hear.

"My personal experience with TN began in 2005. I associated the first painful episode, which lasted for 6 months, with a ruptured eardrum and temporomandibular joint disorder (TMJ). After working with my neurologist on different medications, the pain was greatly reduced. November of 2010, the TN pain level began to increase severely. To mediate the pain, I upped my intake of Trileptal, returning to around 600 mg/day. After a lengthy hospitalization due to the decreased sodium levels from the medication, I knew I needed to find a solution."

"On August 10, I received my first treatment. Pain relief was evident within the first 5 minutes of the first treatment! I was still quite weak and I was suffering from the side effects of the pain medications, but suddenly, the pain was under control! After completing the series of treatments, I finally felt like I had my life back."

Source:

lasermedcenter.com

Posted in: Device / Technology News | Medical Procedure News | Medical Condition News

Tags: , ,

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Finnish | עִבְרִית | Русский | Svenska | Polski
Comments
  1. ross farrokhzad ross farrokhzad United States says:

    Where is the laser beam applied on the patient and what is the mechanism for the reparative changes?

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Polyarticular juvenile idiopathic arthritis (PJIA): an interview with Dr. Kramer, VP, Immunology and Infectious Diseases Medical Unit, Genentech